Skip to main content
article atm-icon bar bell bio cancel-o cancel ch-icon crisis-color crisis cs-icon doc-icon down-angle down-arrow-o down-triangle download email-small email external facebook googleplus hamburger image-icon info-o info instagram left-angle-o left-angle left-arrow-2 left-arrow linkedin loader menu minus-o pdf-icon pencil photography pinterest play-icon plus-o press right-angle-o right-angle right-arrow-o right-arrow right-diag-arrow rss search tags time twitter up-arrow-o videos

Suggested Content

Helping Preemies Survive

  • April 28, 2010

Some premature babies struggle to breathe and turn blue because their lungs are not fully developed and they can’t get enough oxygen. It’s a potentially fatal condition called respiratory distress syndrome. Infants with the most severe cases often die before they are a week old.

They don’t have enough of a protective substance called surfactant that allows their lungs to inflate properly. Premature babies who receive surfactant replacement therapy such as Survanta® at birth have an increased chance of survival.

To help premature infants with respiratory distress syndrome, AmeriCares recently delivered more than $1 million worth of Survanta® generously donated by Abbott to hospitals in Armenia, Eritrea, Guyana, Jamaica, Lebanon, Paraguay, Romania and Sri Lanka.

In Kosovo, where AmeriCares has been delivering Survanta® to neonatal intensive care units since 2006, two-thirds of the 108 babies who received the treatment in 2008 survived. 

“Survanta® prevents the air sacs in the lungs from collapsing when the baby exhales, allowing more oxygen to flow to vital organs,” said AmeriCares Medical Director Dr. Frank Bia. “This is a truly lifesaving biological product that saves the smallest and most fragile patients.”

Donate Now